Covid-19 Impact on Telemedicine Technologies and Services Market Scope
Telemedicine is the practice of using communications technology to link healthcare providers to their patients and each other over great distances. It refers specifically to remote clinical services. Telemedicine offers a means to help transform healthcare itself by encouraging greater consumer involvement in decision making and providing new approaches to maintaining healthy lifestyle services when participants are at different locations. In 2020, the Telemedicine adoption rate has significantly improved owing to the novel coronavirus globally. There was a drastic shift from 11 percent to 76 percent when it came to people who want to use telehealth. North America is the largest telemedicine market globally. Government initiatives and grants to increase the adoption of telemedicine solutions are expected to boost the market in the United Kingdom.
The Covid-19 Impact on Telemedicine Technologies and Services market study is segmented, by Application (Dermatology, Gynecology, Neurology, Cardiology, Orthopedics and Others) and major geographies with country level break-up.
The United Kingdom telemedicine technologies and services market is highly focused on the number of key market players. The players are adopting advanced techniques for the development of products and services to expand their portfolio, geographical reach, increase customer base, and garner market share. Constant upgrade and innovation in products of telemedicine technologies is the key strategy adopted by major players in the market. Research Analyst at AMA estimates that United States Players will contribute to the maximum growth of Global Covid-19 Impact on Telemedicine Technologies and Services market throughout the predicted period.
OBS Medical Ltd. (United Kingdom), Immedicare (United Kingdom), Babylon Health (United Kingdom), NHS (United Kingdom), Push Doctor (United Kingdom), Involve Visual Collaboration Limited (United Kingdom), Tele Medicine Clinic (United Kingdom), GE Healthcare (United States), AMD Global Telemedicine, Inc. (United States) and Honeywell International, Inc. (United States) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research are Abbott (United States), Telemedicine, Inc. (United States), Koninklijke Philips N.V. (Netherlands), Aerotel Medical Systems Ltd. (Israel), F. Hoffmann-La Roche Ltd (Switzerland), GlobalMedia Group LLC (United States), LifeWatch AG (Switzerland), McKesson Corporation (United States), Cardiocom, LLC, (United States) and Medtronic plc (Ireland).
The research aims to propose a patent-based approach in searching for potential technology partners as a supporting tool for enabling open innovation. The study also proposes a systematic searching process of technology partners as a
preliminary step to select the emerging and key players that are involved in implementing market estimations. While patent analysis is employed to overcome the aforementioned data- and process-related limitations, as expenses occurred in that technology allows us to estimate the market size by evolving segments as target market from total available market.
AdvanceMarketAnalytics has segmented the market of Global Covid-19 Impact on Telemedicine Technologies and Services market by Type, Application and Region.
On the basis of geography, the market of Covid-19 Impact on Telemedicine Technologies and Services has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico).
In June 2016, the National Health Service of the United Kingdom announced that it was offering remote monitoring medical devices and apps to help millions of people manage chronic conditions. and In February 2017, Abbott MRI Pacemaker received the United States FDA approval for its novel advanced product MRI Pacemaker for both the Assurity MRI pacemaker and Tendril MRI pacing lead.
- Modern technology such as HIPAA Compliant Video-Conferencing Tools
- Adoption of mHealth, and Artificial Intelligence as a Standard of Care
- Increase in Incidence of Chronic Diseases and Adoption of Telemedicine Solutions
- Rise in Demand for Self-Care Devices/Solutions Such As mHealth and Remote Monitoring
- Increased Traditional Health Care Costs, and Increase in Digital Health Users
- Development in Healthcare Infrastructure and Rise in Telemedicine Products
- Growing Technological Developments in Telemedicine and Healthcare such as Adoption of 5G
- Internet of Medical Things, Blockchain, and Cloud Technology
- Increasing Research & Development Activities to Develop New, Innovative, and Technologically Advanced Products
- Highly Cost-Intensive and Requires Huge Installation Costs
- Privacy and Security Concerns about Patient Information
- Stringent Regulatory Framework
- Lack of Skilled Workforce or Resources
Key Target AudienceTelemedicine Technologies and Services Providers, System and Software Developers, Laboratories & Research Institutes, Hospitals & Clinics, End-Use Industries and Others
Frequently asked questions:1. Is it possible to have certain customization in the study?
The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a study that suits your business objectives.
2. How big is the Covid-19 Impact on Telemedicine Technologies and Services Market?
Yes, the study does represent market size by key business segment, application/end users and major geographies forecasted till 2026.